122 related articles for article (PubMed ID: 28611046)
21. miR-656 inhibits glioma tumorigenesis through repression of BMPR1A.
Guo M; Jiang Z; Zhang X; Lu D; Ha AD; Sun J; Du W; Wu Z; Hu L; Khadarian K; Shen J; Lin Z
Carcinogenesis; 2014 Aug; 35(8):1698-706. PubMed ID: 24480809
[TBL] [Abstract][Full Text] [Related]
22. Targeting of MyD88 Homodimerization by Novel Synthetic Inhibitor TJ-M2010-5 in Preventing Colitis-Associated Colorectal Cancer.
Xie L; Jiang FC; Zhang LM; He WT; Liu JH; Li MQ; Zhang X; Xing S; Guo H; Zhou P
J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26712311
[TBL] [Abstract][Full Text] [Related]
23. Activation of AKT signaling promotes epithelial-mesenchymal transition and tumor growth in colorectal cancer cells.
Suman S; Kurisetty V; Das TP; Vadodkar A; Ramos G; Lakshmanaswamy R; Damodaran C
Mol Carcinog; 2014 Feb; 53 Suppl 1():E151-60. PubMed ID: 24000138
[TBL] [Abstract][Full Text] [Related]
24. MEK plus PI3K/mTORC1/2 Therapeutic Efficacy Is Impacted by TP53 Mutation in Preclinical Models of Colorectal Cancer.
García-García C; Rivas MA; Ibrahim YH; Calvo MT; Gris-Oliver A; Rodríguez O; Grueso J; Antón P; Guzmán M; Aura C; Nuciforo P; Jessen K; Argilés G; Dienstmann R; Bertotti A; Trusolino L; Matito J; Vivancos A; Chicote I; Palmer HG; Tabernero J; Scaltriti M; Baselga J; Serra V
Clin Cancer Res; 2015 Dec; 21(24):5499-5510. PubMed ID: 26272063
[TBL] [Abstract][Full Text] [Related]
25. The cyclin-dependent kinase inhibitor SNS-032 induces apoptosis in breast cancer cells via depletion of Mcl-1 and X-linked inhibitor of apoptosis protein and displays antitumor activity in vivo.
Xie G; Tang H; Wu S; Chen J; Liu J; Liao C
Int J Oncol; 2014 Aug; 45(2):804-12. PubMed ID: 24865236
[TBL] [Abstract][Full Text] [Related]
26. Co-targeting of Cyclooxygenase-2 and FoxM1 is a viable strategy in inducing anticancer effects in colorectal cancer cells.
Ahmed M; Hussain AR; Siraj AK; Uddin S; Al-Sanea N; Al-Dayel F; Al-Assiri M; Beg S; Al-Kuraya KS
Mol Cancer; 2015 Jul; 14():131. PubMed ID: 26159723
[TBL] [Abstract][Full Text] [Related]
27. Gambogic acid induces apoptosis and inhibits colorectal tumor growth via mitochondrial pathways.
Huang GM; Sun Y; Ge X; Wan X; Li CB
World J Gastroenterol; 2015 May; 21(20):6194-205. PubMed ID: 26034354
[TBL] [Abstract][Full Text] [Related]
28. Primary and acquired resistance of colorectal cancer cells to anti-EGFR antibodies converge on MEK/ERK pathway activation and can be overcome by combined MEK/EGFR inhibition.
Troiani T; Napolitano S; Vitagliano D; Morgillo F; Capasso A; Sforza V; Nappi A; Ciardiello D; Ciardiello F; Martinelli E
Clin Cancer Res; 2014 Jul; 20(14):3775-86. PubMed ID: 24812410
[TBL] [Abstract][Full Text] [Related]
29. Dragon (repulsive guidance molecule b, RGMb) is a novel gene that promotes colorectal cancer growth.
Shi Y; Chen GB; Huang XX; Xiao CX; Wang HH; Li YS; Zhang JF; Li S; Xia Y; Ren JL; Guleng B
Oncotarget; 2015 Aug; 6(24):20540-54. PubMed ID: 26029998
[TBL] [Abstract][Full Text] [Related]
30. DC120, a novel and potent inhibitor of AKT kinase, induces tumor cell apoptosis and suppresses tumor growth.
Deng R; Yang F; Chang SH; Tang J; Qin J; Feng GK; Ding K; Zhu XF
Mol Pharmacol; 2012 Aug; 82(2):189-98. PubMed ID: 22553359
[TBL] [Abstract][Full Text] [Related]
31. BMP-6 inhibits cell proliferation by targeting microRNA-192 in breast cancer.
Hu F; Meng X; Tong Q; Liang L; Xiang R; Zhu T; Yang S
Biochim Biophys Acta; 2013 Dec; 1832(12):2379-90. PubMed ID: 24012720
[TBL] [Abstract][Full Text] [Related]
32. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.
Wang L; Chen W; Xie X; He Y; Bai X
Exp Oncol; 2008 Mar; 30(1):42-51. PubMed ID: 18438340
[TBL] [Abstract][Full Text] [Related]
33. Combined epidermal growth factor receptor targeting with the tyrosine kinase inhibitor gefitinib (ZD1839) and the monoclonal antibody cetuximab (IMC-C225): superiority over single-agent receptor targeting.
Matar P; Rojo F; Cassia R; Moreno-Bueno G; Di Cosimo S; Tabernero J; Guzmán M; Rodriguez S; Arribas J; Palacios J; Baselga J
Clin Cancer Res; 2004 Oct; 10(19):6487-501. PubMed ID: 15475436
[TBL] [Abstract][Full Text] [Related]
34. Oleanolic acid modulates multiple intracellular targets to inhibit colorectal cancer growth.
Li L; Wei L; Shen A; Chu J; Lin J; Peng J
Int J Oncol; 2015 Dec; 47(6):2247-54. PubMed ID: 26459864
[TBL] [Abstract][Full Text] [Related]
35. Dihydromyricetin activates AMP-activated protein kinase and P38(MAPK) exerting antitumor potential in osteosarcoma.
Zhao Z; Yin JQ; Wu MS; Song G; Xie XB; Zou C; Tang Q; Wu Y; Lu J; Wang Y; Wang J; Kang T; Jia Q; Shen J
Cancer Prev Res (Phila); 2014 Sep; 7(9):927-38. PubMed ID: 24894198
[TBL] [Abstract][Full Text] [Related]
36. The antitumor activity of TRAIL and IL-24 with replicating oncolytic adenovirus in colorectal cancer.
Zhao L; Dong A; Gu J; Liu Z; Zhang Y; Zhang W; Wang Y; He L; Qian C; Qian Q; Liu X
Cancer Gene Ther; 2006 Nov; 13(11):1011-22. PubMed ID: 16799468
[TBL] [Abstract][Full Text] [Related]
37. A novel antitumor piperazine alkyl compound causes apoptosis by inducing RhoB expression via ROS‑mediated c‑Abl/p38 MAPK signaling.
Chung KS; Han G; Kim BK; Kim HM; Yang JS; Ahn J; Lee K; Song KB; Won M
Cancer Chemother Pharmacol; 2013 Dec; 72(6):1315-24. PubMed ID: 24121479
[TBL] [Abstract][Full Text] [Related]
38. Identification of the role of bone morphogenetic protein (BMP) and transforming growth factor-β (TGF-β) signaling in the trajectory of serotonergic differentiation in a rapid assay in mouse embryonic stem cells in vitro.
Yamasaki A; Kasai A; Toi A; Kurita M; Kimoto S; Hayata-Takano A; Nakazawa T; Nagayasu K; Shintani N; Hashimoto R; Ito A; Meltzer HY; Ago Y; Waschek JA; Onaka Y; Matsuda T; Baba A; Hashimoto H
J Neurochem; 2015 Feb; 132(4):418-28. PubMed ID: 25421849
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of BMP and of TGFβ receptors downregulates expression of XIAP and TAK1 leading to lung cancer cell death.
Augeri DJ; Langenfeld E; Castle M; Gilleran JA; Langenfeld J
Mol Cancer; 2016 Apr; 15():27. PubMed ID: 27048361
[TBL] [Abstract][Full Text] [Related]
40. Silencing Bag-1 gene via magnetic gold nanoparticle-delivered siRNA plasmid for colorectal cancer therapy in vivo and in vitro.
Huang W; Liu Z; Zhou G; Ling J; Tian A; Sun N
Tumour Biol; 2016 Aug; 37(8):10365-74. PubMed ID: 26846101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
